Sorry I should have mentioned that there are other cardiac markers aside from Troponin, although from my understanding they are part of the suite mentioned
"bioMerieux is already recognized among clinicians for its high medical value tests, which include the VIDAS range of cardiac emergency markers: Troponin I Ultra, Myoglobin, CK-MB, D-Dimer and NT-proBNP. The solutions co-developed with Philips will be complementary to VIDAS, giving clinicians the option of point-of-care testing without compromising on assay performance"
I guess of you have chest pain, get yourself into the hospital quick smart, I was amazed by that 10 days survival for every one minute prior to intervention statistic, probably just the nerd in me..........
- Forums
- ASX - By Stock
- ADO
- Ann: 2012 Annual Report
Ann: 2012 Annual Report , page-20
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.001(5.00%) |
Mkt cap ! $51.83M |
Open | High | Low | Value | Volume |
2.1¢ | 2.1¢ | 2.0¢ | $16.09K | 770.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 3814417 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 433979 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 3814417 | 0.020 |
10 | 3104136 | 0.019 |
9 | 1917888 | 0.018 |
8 | 1211559 | 0.017 |
6 | 963251 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 433979 | 4 |
0.022 | 400500 | 4 |
0.023 | 879953 | 6 |
0.024 | 1266228 | 4 |
0.025 | 195344 | 4 |
Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online